AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 216 filers reported holding AMICUS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,948 | -9.2% | 356 | 0.0% | 0.00% | – |
| Q4 2022 | $4,346 | +8.6% | 356 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 356 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | +33.3% | 356 | 0.0% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 356 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | +33.3% | 356 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 356 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | -25.0% | 356 | 0.0% | 0.00% | – |
| Q1 2021 | $4,000 | -50.0% | 356 | 0.0% | 0.00% | – |
| Q4 2020 | $8,000 | +60.0% | 356 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | 0.0% | 356 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 356 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 356 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 356 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | – | 356 | +1086.7% | 0.00% | – |
| Q4 2018 | $0 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |